SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 10, Pages 3534
Publisher
MDPI AG
Online
2020-05-18
DOI
10.3390/ijms21103534
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular subtypes of pancreatic cancer
- (2019) Eric A. Collisson et al. Nature Reviews Gastroenterology & Hepatology
- Transforming growth factor-β in pancreatic diseases: Mechanisms and therapeutic potential
- (2019) Qi Zhou et al. PHARMACOLOGICAL RESEARCH
- Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
- (2019) Talia Golan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced morphological and functional differences of pancreatic cancer with epithelial or mesenchymal characteristics in 3D culture
- (2019) Yuuki Shichi et al. Scientific Reports
- Integration of Bioinformatics Resources Reveals the Therapeutic Benefits of Gemcitabine and Cell Cycle Intervention in SMAD4-Deleted Pancreatic Ductal Adenocarcinoma
- (2019) Yao-Yu Hsieh et al. Genes
- SMAD4 Y353C promotes the progression of PDAC
- (2019) Zusen Wang et al. BMC CANCER
- Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer
- (2019) Chen Liang et al. GUT
- The prognostic role of soluble TGF‐beta and its dynamics in unresectable pancreatic cancer treated with chemotherapy
- (2019) Hyunkyung Park et al. Cancer Medicine
- The role of TGF-β/SMAD4 signaling in cancer
- (2018) Ming Zhao et al. International Journal of Biological Sciences
- FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
- (2018) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Impact of SMAD4 Loss on Outcome in Patients with Advanced Pancreatic Cancer Treated with Systemic Chemotherapy
- (2017) Steffen Ormanns et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The TGF-β/Smad4 Signaling Pathway in Pancreatic Carcinogenesis and Its Clinical Significance
- (2017) Sunjida Ahmed et al. Journal of Clinical Medicine
- Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma
- (2016) Chen Liang et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- T-cell programming in pancreatic adenocarcinoma: a review
- (2016) Y D Seo et al. CANCER GENE THERAPY
- TGF-β Tumor Suppression through a Lethal EMT
- (2016) Charles J. David et al. CELL
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells
- (2016) Michael Friberg Bruun Nielsen et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Smad4 inhibits cell migration via suppression of JNK activity in human pancreatic carcinoma PANC-1 cells
- (2016) XUEYING ZHANG et al. Oncology Letters
- Cancer of the Pancreas: Molecular Pathways and Current Advancement in Treatment
- (2016) Kishore Polireddy et al. Journal of Cancer
- Pancreatic cancer
- (2016) Jorg Kleeff et al. Nature Reviews Disease Primers
- Mechanisms of TGFβ-Induced Epithelial–Mesenchymal Transition
- (2016) Aristidis Moustakas et al. Journal of Clinical Medicine
- Metabolic tumor burden is associated with major oncogenomic alterations and serum tumor markers in patients with resected pancreatic cancer
- (2015) Si Shi et al. CANCER LETTERS
- Whole genomes redefine the mutational landscape of pancreatic cancer
- (2015) Nicola Waddell et al. NATURE
- SMAD4 Expression Predicts Local Spread and Treatment Failure in Resected Pancreatic Cancer
- (2015) Suguru Yamada et al. PANCREAS
- Structural determinants of Smad function in TGF-β signaling
- (2015) Maria J. Macias et al. TRENDS IN BIOCHEMICAL SCIENCES
- MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4
- (2015) Xiang Xia et al. Oncotarget
- SMAD4 Loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells
- (2014) Yu-Wen Chen et al. BMC CANCER
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- TGF- : Duality of Function Between Tumor Prevention and Carcinogenesis
- (2014) D. R. Principe et al. JNCI-Journal of the National Cancer Institute
- Biomarkers of TGF-β Signaling Pathway and Prognosis of Pancreatic Cancer
- (2014) Milind Javle et al. PLoS One
- SMAD4 and its role in pancreatic cancer
- (2014) Xiang Xia et al. TUMOR BIOLOGY
- The Tumor Suppressor Smad4/DPC4 Is Regulated by Phosphorylations that Integrate FGF, Wnt, and TGF-β Signaling
- (2014) Hadrien Demagny et al. Cell Reports
- Immunohistochemically Detected Expression of 3 Major Genes (CDKN2A/p16, TP53, and SMAD4/DPC4) Strongly Predicts Survival in Patients With Resectable Pancreatic Cancer
- (2013) Minoru Oshima et al. ANNALS OF SURGERY
- Failure Patterns in Resected Pancreas Adenocarcinoma
- (2013) Jordan M. Winter et al. ANNALS OF SURGERY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetically Defined Subsets of Human Pancreatic Cancer Show Unique In Vitro Chemosensitivity
- (2012) Y. Cui et al. CLINICAL CANCER RESEARCH
- TGF-β – an excellent servant but a bad master
- (2012) Lenka Kubiczkova et al. Journal of Translational Medicine
- TGFβ signalling in context
- (2012) Joan Massagué NATURE REVIEWS MOLECULAR CELL BIOLOGY
- MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer
- (2011) Jun Hao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Non-Smad signaling pathways
- (2011) Yabing Mu et al. CELL AND TISSUE RESEARCH
- Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression
- (2011) Michael K. Wendt et al. CELL AND TISSUE RESEARCH
- Transforming Growth Factor-β in the Gastrointestinal and Hepatic Tumor Microenvironment
- (2011) Bhagelu Ram Achyut et al. GASTROENTEROLOGY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emergence of the Phosphoinositide 3-Kinase-Akt- Mammalian Target of Rapamycin Axis in Transforming Growth Factor-β-Induced Epithelial-Mesenchymal Transition
- (2010) Samy Lamouille et al. CELLS TISSUES ORGANS
- Transforming growth factor-β and the hallmarks of cancer
- (2010) Maozhen Tian et al. CELLULAR SIGNALLING
- MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer
- (2010) Jun Hao et al. FEBS LETTERS
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer
- (2009) A. Blackford et al. CLINICAL CANCER RESEARCH
- Ubiquitin Ligase Nedd4L Targets Activated Smad2/3 to Limit TGF-β Signaling
- (2009) Sheng Gao et al. MOLECULAR CELL
- Identification and Characterization of a Novel Anticancer Agent With Selectivity Against Deleted in Pancreatic Cancer Locus 4 (DPC4)-Deficient Pancreatic and Colon Cancer Cells
- (2009) Hong Wang et al. PANCREAS
- New regulatory mechanisms of TGF-β receptor function
- (2009) Jong Seok Kang et al. TRENDS IN CELL BIOLOGY
- TGFβ in Cancer
- (2008) Joan Massagué CELL
- TRAF6 Mediates Smad-Independent Activation of JNK and p38 by TGF-β
- (2008) Motozo Yamashita et al. MOLECULAR CELL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started